Awardee OrganizationNEW YORK UNIVERSITY SCHOOL OF MEDICINE
Description
Abstract Text
DESCRIPTION: We are requesting funds for a Seahorse XF automated cellular respiration and glycolysis analyzer. This instrument is the only instrument on the market that can assess cellular respiration and glycolysis in physiologically relevant cellular models, through non-invasive measurements that provide real time kinetic results. Currently, there is no available capability to
measure cellular respiration at NYULMC. The Seahorse XF will be placed within the Research Support Core at NYULMC, and compliment an existing fleet of user based instruments aimed at increasing the efficiency of and supporting translational research. This Core is administered by the Office of Collaborative Science and overseen by an experienced staff. The institution will support the instrument and the instrument internal review board will administer instrument oversight. NYUSOM Office of Collaborative Science, will generate the business plan for the Research Support Core, maintain the service contract, and put a system in place for scheduling and billing. The major user group spans 13 academic departments and represents both basic and translational research areas such as; aging, cardiovascular, cancer, immunology and mitochondrial disorders. The 9 NIH funded users combined will use 80% of the instrument capacity. The minor users group will occupy between 10% of instrument capacity. Remaining instrument capacity will be made available to any internal or external researcher through an on-line scheduler. The availability of this instrument in a Core setting will be unique in Lower Manhattan and we expect to serve NIH funded researchers from all surrounding institutions and resolve the cell viability issue that many researchers face when trying to transport assays from Lower Manhattan to the only other externally-available, Core based instrument located at the Albert Einstein College of Medicine (Bronx, NY).
Public Health Relevance Statement
Data not available.
NIH Spending Category
Biotechnology
Project Terms
AgingAreaBasic ScienceBiological AssayBusinessesCancer Immunology ScienceCardiovascular systemCell RespirationCell SurvivalCell modelContract ServicesFaceFundingGenus HippocampusGlycolysisInstitutionKineticsMarketingMeasurementMeasuresMedicineMinorMitochondrial DiseasesResearch PersonnelResearch SupportScheduleScienceSystemTimeTranslational ResearchUnited States National Institutes of Healthbasecollegeexperienceinstrument
OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH
$125,997
Biotechnology
Sub Projects
No Sub Projects information available for 1S10OD016304-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1S10OD016304-01
Patents
No Patents information available for 1S10OD016304-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1S10OD016304-01
Clinical Studies
No Clinical Studies information available for 1S10OD016304-01
News and More
Related News Releases
No news release information available for 1S10OD016304-01
History
No Historical information available for 1S10OD016304-01
Similar Projects
No Similar Projects information available for 1S10OD016304-01